"The huge global diabetic population is driving growth in the overall Insulin Delivery Systems Market", says RNCOS.
(prHWY.com) January 7, 2013 - NOIDA, India -- A new research report entitled, "Insulin Delivery Systems Market Forecast to 2014", from RNCOS says that huge global diabetic population and their rising demands is driving growth in the overall Insulin Delivery Systems Market. Nations across the world have very high rates of diabetics and this number has been found to be ever increasing. China has the highest number of people affected with diabetes. In 2011, around 90 Million Chinese suffered from diabetes and these figures are expected to grow up to around 129.7 Million by 2030. India has the second highest number of people affected with diabetes. In 2011, around 61 Million Indians had diabetes and these figures too are likely to increase enormously by 2030.
Insulin delivery systems are growing in the market, primarily due to changed consumer preferences towards convenient and painless blood glucose testing methodologies. Insulin syringes have been used traditionally for delivering insulin but the market has witnessed rapid displacement towards alternate insulin delivery systems, such as insulin pens, insulin pumps, and jet injectors. Amongst these, insulin pens, with highly promising developments, form the fastest growing segment in the insulin delivery devices market. With several new launches and ongoing research, discovery and development, it is estimated that the global insulin delivery systems market will grow at a CAGR of around 8% during 2012-2014.
Further, the report, "Insulin Delivery Systems Market Forecast to 2014", by RNCOS is spread over in 85 pages and provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery system market. A global picture of the diabetes prevalent market with high propensity for overall usage of insulin delivery systems is discussed. The report also provides a geographical analysis of insulin delivery systems prevalent in the key diabetic countries. Our study leads to the proposition that innovation has huge scope in this field and we have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader.
For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM369.htm
Some of our Related Reports are:
- US Proton Therapy Market Analysis to 2017 (
http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (
http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (
http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (
http://www.rncos.com/Report/IM450.htm)
- US Cardiac Device Market Analysis (
http://www.rncos.com/Report/IM441.htm)
Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
###